A New York drug discovery company applying generative AI to induced proximity, designing molecules that rewire interactions between proteins.
EPFL / VantAI / University of Oxford / Aithyra
Released February 24, 2025
Structure-based drug design generator pairing continuous flow matching with discrete Markov bridges to sample 3D ligands inside a protein pocket.